Clinical Relevance of Improved Microbleed Detection by Susceptibility-Weighted Magnetic Resonance Imaging

  title={Clinical Relevance of Improved Microbleed Detection by Susceptibility-Weighted Magnetic Resonance Imaging},
  author={Jeroen Dirk Cornelis Goos and Wiesje Maria van der Flier and Dirk L. Knol and Petra J. W. Pouwels and Philip Scheltens and Frederik Barkhof and Mike P. Wattjes},
Background and Purpose— Susceptibility-weighted imaging (SWI) has been shown to be more sensitive in detecting cerebral microbleeds (MBs) than is conventional T2*-weighted gradient-recalled echo imaging (GRE). However, the clinical relevance of this improved detection in terms of associations with clinical measures and risk factors is unclear. We sought to determine whether associations of MBs with clinical characteristics, risk factors, white-matter hyperintensities, and lacunes were different… 

Figures and Tables from this paper

Susceptibility-Weighted Imaging is More Reliable Than T2*-Weighted Gradient-Recalled Echo MRI for Detecting Microbleeds

SWI confers greater reliability as well as greater sensitivity for CMB detection compared with GRE, and should be the preferred sequence for quantifying CMB counts.

MRI detection of cerebral microbleeds: size matters

Evidently, in addition to size, other factors will influence the detectability of CMB, including iron content, ratio of Fe2+/Fe3+, spatial configuration, and location, yet this remains to be elucidated in future studies.

Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings

A guide to the detection and clinical relevance of cerebral microbleeds in different conditions based on a comprehensive review of the literature and own findings in research and clinical practice is provided.

Wave-CAIPI susceptibility-weighted imaging achieves diagnostic performance comparable to conventional susceptibility-weighted imaging in half the scan time

Wave-CAIPI SWI achieves a diagnostic performance for the detection of cerebral microbleeds that is comparable to that of conventional SWI in half the scan time, and interobserver agreements were excellent.

Cerebral Microbleeds in an Acute Ischemic Stroke as a Predictor of Hemorrhagic Transformation

Microbleeds detected on an SWI scan is a relevant and accurate predictor of hemorrhagic transformations in acute ischemic infarcts and should be added to MRI stroke protocols.

Cerebral Microbleeds Remain for Nine Years: A Prospective Study with Yearly Magnetic Resonance Imaging.

Cerebral Microbleeds: A Review of Clinical, Genetic, and Neuroimaging Associations

The presence of microbleeds has been suggested to confer increased risk of incident intracerebral hemorrhage – particularly in the setting of anticoagulation – and of complications of immunotherapy for AD.

Cerebral microbleeds as a marker of small vessel disease : new insights from neuro-imaging and clinical studies in stroke patients

CMBs have useful roles in understanding pathophysiology, diagnosis and prognosis in patients with small vessel diseases, and are associated with markers of small vessel disease severity, including CMBs.



MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility-Weighted Imaging, Section Thickness, and Field Strength

An analysis of sequence, section thickness, and field strength on CMB imaging properties and detection in subjects with cerebral amyloid angiopathy, a condition associated with microhemorrhage yields substantially improved CMB contrast and sensitivity for detection.

The Microbleed Anatomical Rating Scale (MARS)

The Microbleed Anatomical Rating Scale has good intrarater and interrater reliability for the presence of definite microbleeds in all brain locations when applied to different MRI sequences and levels of observer experience.

Cerebral microbleeds in Alzheimer’s disease

T2*-weighted gradient-echo magnetic resonance imaging (MRI) scans were obtained to determine the frequency, extent, and pattern of MBs in patients with Alzheimer’s disease (AD), and MBs were defined on gradient- echo T2*weighted images as homogenous rounded lesions of signal loss with a diameter greater than 2 mm.

Clinical and radiologic differences between primary intracerebral hemorrhage with and without microbleeds on gradient-echo magnetic resonance images.

Primary intracerebral hemorrhage without microbleed was more common in younger patients with precipitating events, whereas PICH with microbleeds was moreCommon in elderly patients with prominent ischemic change and frequent use of antithrombotics or anticoagulants.

Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting.

Brain microbleeds are seen as small, homogeneous, round foci of low signal intensity on magnetic resonance imaging gradient echo (GRE) T2 sequences and it appears that they are associated with hypertension and diabetes mellitus in otherwise healthy adults and adults with cerebrovascular diseases.

Microbleeds in Moyamoya Disease: Susceptibility-Weighted Imaging Versus T2*-Weighted Imaging at 3 Tesla

SWI offers better detectability of MBs in MMD than T2*WI at 3 T, and Lesions displayed greater visual grading score on SWI than on T 2*WI (P < 0.0001).

Silent Cerebral Microbleeds on T2*-Weighted MRI: Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis

The findings suggest that microbleeds on T2*-weighted MRI are an indicator of advanced small artery disease of the brain with an increased risk for bleeding in patients with stroke.

Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.

Novel evidence is provided that microbleeds are associated with cognitive dysfunction, independent of the extent of MRI-visible white matter changes of presumed ischaemic origin, or the presence ofIschaemic stroke.

Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study

Correlation of imaging findings to tissue pathology in postmortem brains with Alzheimer's disease (AD) indicates that a variety of CAA-related pathologies produce MR-identified signal voids and further supports the use of SWI as a biomarker for this disease.